Statistics for Esperion Therapeutics (id:6808 ESPR)

Valuation metrics

Market cap

423.63M

Enterprise value

541.96M

Trailing P/E (ttm)

-1.19

Forward P/E

10.75

PEG ratio

10.75

Price/Sales (ttm)

1.43

Price/Book (mrq)

-1.27

Enterprise Value/Revenue

1.83

Enterprise Value/EBITDA

32.85

Overview

Shares outstanding

197.04M

Float

195.63M

Shares short

33.46M

% Held by insiders

0.00%

% Held by institutions

0.66%

Average volume (10 days)

7.27M

Average volume (90 days)

Price summary

52-Week low

1.16

52-Week high

3.40

52-Week change

48.13%

Beta

0.95

50-Day moving average

1.97

200-Day moving average

2.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-29.37%

Operating margin

-31.04%

Operational effectiveness

Return on assets

3.84%

Return on equity

45.99%

Income statement

Revenue (ttm)

1.78

Revenue per share (ttm)

1.78

Quarterly revenue growth (yoy)

Gross profit (ttm)

73.07M

EBITDA

16.50M

Net income to common (ttm)

-86,771,000.00

Diluted EPS (ttm)

-0.67

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

144.72M

Total cash per share (mrq)

0.73

Total debt (mrq)

268.96M

Total Debt/Equity (mrq)

-0.73

Current ratio (mrq)

185.40%

Book value per share (mrq)

-1.89

Cash flow

Cash flow statement

-25,758,000.00

Levered free cash flow (LFCF)

-8,951,375.00